1
|
Mendoza-Cervantes D, Otero I, Zujewski JA, Ferrandiz Salazar J, López Córdova G, Muha C, Stevens L. Building a Network of Health Professionals for Breast and Cervical Cancer Control in the Andean Region. J Glob Oncol 2018; 4:1-8. [PMID: 30241215 PMCID: PMC6180811 DOI: 10.1200/jgo.2016.008714] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
PURPOSE Cancer mortality is approximately twice as high in Latin American countries than in more developed countries. In particular, the countries of the high Andean region of Latin America carry a double burden of breast and cervical cancers. In these countries, there are disproportionately higher mortality to incidence ratios compared with other regions in Latin America. The US National Cancer Institute's Center for Global Health, the Pan American Health Organization, and the Ministry of Health in Peru collaborated to design and execute an education and advocacy workshop in Lima, Peru. The workshop was convened to discuss regional challenges and practices, as well as to support the implementation of Plan Esperanza, Peru's national cancer control plan. METHODS Workshop participants included local and international experts to present the state of the science, health practitioners, and advocacy groups to discuss unique barriers that women in the region experience. RESULTS Inequalities in access to and distribution of medical expertise, lack of continuity of cancer control plans, and the need for sustained public buy-in emerged as obstacles. CONCLUSION The workshop provided a forum to discuss key issues regarding breast and cervical cancer control among health professionals and advocates in Peru and the region. This article outlines the resulting recommendations.
Collapse
Affiliation(s)
- Diana Mendoza-Cervantes
- Diana Mendoza-Cervantes, Isabel Otero,
Jo Anne Zujewski, Cathy Muha, and Lisa
Stevens, National Institutes of Health, Rockville, MD; and
Jorge Ferrandiz Salazar and Gabriela López
Córdova, Ministerio de Salud de Perú, Jesús
María, Lima, Peru
| | - Isabel Otero
- Diana Mendoza-Cervantes, Isabel Otero,
Jo Anne Zujewski, Cathy Muha, and Lisa
Stevens, National Institutes of Health, Rockville, MD; and
Jorge Ferrandiz Salazar and Gabriela López
Córdova, Ministerio de Salud de Perú, Jesús
María, Lima, Peru
| | - Jo Anne Zujewski
- Diana Mendoza-Cervantes, Isabel Otero,
Jo Anne Zujewski, Cathy Muha, and Lisa
Stevens, National Institutes of Health, Rockville, MD; and
Jorge Ferrandiz Salazar and Gabriela López
Córdova, Ministerio de Salud de Perú, Jesús
María, Lima, Peru
| | - Jorge Ferrandiz Salazar
- Diana Mendoza-Cervantes, Isabel Otero,
Jo Anne Zujewski, Cathy Muha, and Lisa
Stevens, National Institutes of Health, Rockville, MD; and
Jorge Ferrandiz Salazar and Gabriela López
Córdova, Ministerio de Salud de Perú, Jesús
María, Lima, Peru
| | - Gabriela López Córdova
- Diana Mendoza-Cervantes, Isabel Otero,
Jo Anne Zujewski, Cathy Muha, and Lisa
Stevens, National Institutes of Health, Rockville, MD; and
Jorge Ferrandiz Salazar and Gabriela López
Córdova, Ministerio de Salud de Perú, Jesús
María, Lima, Peru
| | - Cathy Muha
- Diana Mendoza-Cervantes, Isabel Otero,
Jo Anne Zujewski, Cathy Muha, and Lisa
Stevens, National Institutes of Health, Rockville, MD; and
Jorge Ferrandiz Salazar and Gabriela López
Córdova, Ministerio de Salud de Perú, Jesús
María, Lima, Peru
| | - Lisa Stevens
- Diana Mendoza-Cervantes, Isabel Otero,
Jo Anne Zujewski, Cathy Muha, and Lisa
Stevens, National Institutes of Health, Rockville, MD; and
Jorge Ferrandiz Salazar and Gabriela López
Córdova, Ministerio de Salud de Perú, Jesús
María, Lima, Peru
| |
Collapse
|
2
|
Vidaurre T, Santos C, Gómez H, Sarria G, Amorin E, López M, Regalado R, Manrique J, Tarco D, Ayestas C, Calderón M, Mas L, Neciosup S, Salazar M, Chávez JC, Ubillus M, Limache A, Ubillus JC, Navarro J, Sarwal K, Sutcliffe S, Gutiérrez-Aguado A, Silva M, Mena A, Guillén ME, Castañeda C, Abugattas J. The implementation of the Plan Esperanza and response to the imPACT Review. Lancet Oncol 2017; 18:e595-e606. [PMID: 28971826 DOI: 10.1016/s1470-2045(17)30598-3] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2016] [Revised: 07/26/2017] [Accepted: 07/27/2017] [Indexed: 10/18/2022]
Abstract
Following the implementation of the National Cancer Prevention and Control Results-based Budget Programme (PpR Cancer-024) in 2011, the Peruvian Government approved the Plan Esperanza-a population-based national cancer control plan-in 2012. Legislation that ensured full government-supported funding for people who were otherwise unable to access or afford care and treatment accompanied the Plan. In 2013, the Ministry of Health requested an integrated mission of the Programme of Action for Cancer Therapy (imPACT) report to strengthen cancer control in Peru. The imPACT Review, which was executed in 2014, assessed Peru's achievements in cancer control, and areas for improvement, including cancer control planning, further development of population-based cancer registration, increased prevention, early diagnosis, treatment and palliative care, and the engagement and participation of civil society in the health-care system. This Series paper gives a brief history of the development of the Plan Esperanza, describes the innovative funding model that supports it, and summarises how funds are disseminated on the basis of disease, geography, and demographics. An overview of the imPACT Review, and the government's response in the context of the Plan Esperanza, is provided. The development and execution of the Plan Esperanza and the execution of and response to the imPACT Review demonstrates the Peruvian Government's commitment to fighting cancer across the country, including in remote and urban areas.
Collapse
Affiliation(s)
| | - Carlos Santos
- National Institute of Neoplastic Diseases, Lima, Peru
| | - Henry Gómez
- National Institute of Neoplastic Diseases, Lima, Peru
| | | | - Edgar Amorin
- National Institute of Neoplastic Diseases, Lima, Peru
| | - Marga López
- National Institute of Neoplastic Diseases, Lima, Peru
| | | | | | | | | | | | - Luis Mas
- National Institute of Neoplastic Diseases, Lima, Peru
| | | | | | | | | | - Abel Limache
- National Institute of Neoplastic Diseases, Lima, Peru
| | | | | | - Kavita Sarwal
- International Cancer Control Congress Association, Canada
| | | | | | | | - Amalia Mena
- Intangible Solidarity Health Fund, Lima, Peru
| | | | | | | |
Collapse
|